Five months after gene transfer, a highly significant reduction in glucocerebroside accumulation with subsequent reversal of hepatosplenomegaly, restoration of blood parameters, and a tendency of increased bone mass and density was evident in vector-treated mice compared to non-treated controls.
← all excerpts
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector.
1
—
—